Studies have shown that tumour-conditioned medium (TCM) collected from the supernatant of human primary glioma cells can upregulate the expression of suppressor of cytokine signalling 1 (SOCS1) in DCs and then inhibit the NF-κB signalling pathway, thereby limiting the maturation of DCs. The gene discussed is SOCS1; the disease is glioma.